Kala Pharmaceuticals

Waltham,  MA 
United States
http://www.kalarx.com
  • Booth: 205

Kala Pharmaceuticals welcomes you.

Kala Pharmaceuticals, Inc. is a biopharma company focused on development and commercialization or products using our proprietary mucus-penetrating particle (MPP) technology. Kala is initially focused on the treatment of eye diseases. We’ve applied our MPP technology to create nanosuspensions of loteprednol etabonate, a corticosteroid designed for ocular applications, resulting in our two lead product candidates; INVELTYS for the treatment of inflammation and pain following ocular surgery. INVELTYS has a PDUFA date in late-August 2018. Our second formulation is for the temporary relief of the signs and symptoms of dry eye disease. Kala went public in 2017.

Brands: INVELTYS for the treatment of inflammation and pain following ocular surgery. INVELTYS has a PDUFA date in late-August 2018. Our second formulation is for the temporary relief of the signs and symptoms of dry eye disease.


Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".


For Technical Support with this webpage, please contact support.